Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
EBERHARD, David A, JOHNSON, Bruce E, KLEIN, Pam, MILLER, Vincent A, OSTLAND, Michael A, RAMIES, David A, SEBISANOVIC, Dragan, STINSON, Jeremy A, ZHANG, Yu R, SESHAGIRI, Somasekar, HILLAN, Kenneth J, AMLER, Lukas C, GODDARD, Audrey D, HELDENS, Sherry L, HERBST, Roy S, INCE, William L, JÄNNE, Pasi A, JANUARIO, Thomas, JOHNSON, David H
Published in Journal of clinical oncology (01.09.2005)
Published in Journal of clinical oncology (01.09.2005)
Get full text
Journal Article
Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer
HERBST, Roy S, JOHNSON, David H, HONG, Waun K, TRAN, Hai, TSAO, Anne, DONG XIE, RAMIES, David A, MASS, Robert, SESHAGIRI, Somasekar, EBERHARD, David A, KELLEY, Sean K, SANDLER, Alan, MININBERG, Eric, CARBONE, David P, HENDERSON, Ted, KIM, Edward S, BLUMENSCHEIN, George JR, LEE, Jack J, LIU, Diane D, TRUONG, Mylene T
Published in Journal of clinical oncology (10.04.2005)
Published in Journal of clinical oncology (10.04.2005)
Get full text
Journal Article
Conference Proceeding
Results of a Phase II Placebo-controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non–small-cell Lung Carcinoma
Hellerstedt, Beth A., Vogelzang, Nicholas J., Kluger, Harriet M., Yasenchak, Christopher A., Aftab, Dana T., Ramies, David A., Gordon, Michael S., Lara, Primo
Published in Clinical lung cancer (01.03.2019)
Published in Clinical lung cancer (01.03.2019)
Get full text
Journal Article
Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): Early termination due to increased toxicities
MESSERSMITH, Wells A, LAHERU, Daniel A, SENZER, Neil N, DONEHOWER, Ross C, GROULEFF, Paula, ROGERS, Theresa, KELLEY, Sean K, RAMIES, David A, LUM, Bert L, HIDALGO, Manuel
Published in Clinical cancer research (01.10.2004)
Published in Clinical cancer research (01.10.2004)
Get full text
Journal Article
Activity of cabozantinib (XL184) in hepatocellular carcinoma: Results from a phase II randomized discontinuation trial (RDT)
Verslype, Chris, Cohn, Allen Lee, Kelley, Robin Katie, Yang, Tsai-Shen, Su, Wu-Chou, Ramies, David A., Lee, Yihua, Shen, Xiaodong, Van Cutsem, Eric
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Activity of cabozantinib (XL184) in hepatocellular carcinoma patients (pts): Results from a phase II randomized discontinuation trial (RDT)
Cohn, Allen Lee, Kelley, Robin Katie, Yang, Tsai-Shen, Su, Wu-Chou, Verslype, Chris, Ramies, David A., Lee, Yihua, Shen, Xiaodong, Van Cutsem, Eric
Published in Journal of clinical oncology (01.02.2012)
Published in Journal of clinical oncology (01.02.2012)
Get full text
Journal Article
Phase I Trial of Irinotecan, Infusional 5-Fluorouracil, and Leucovorin (FOLFIRI) with Erlotinib (OSI-774)
Messersmith, Wells A., Laheru, Daniel A., Senzer, Neil N., Donehower, Ross C., Grouleff, Paula, Rogers, Theresa, Kelley, Sean K., Ramies, David A., Lum, Bert L., Hidalgo, Manuel
Published in Clinical cancer research (01.10.2004)
Published in Clinical cancer research (01.10.2004)
Get full text
Journal Article
Phase II study of lower-dose pracinostat plus azacitidine safety and efficacy in patients with high/very high-risk myelodysplastic syndromes
Atallah, Ehab L., Khaled, Samer K., Cooper, Brenda W., Warlick, Erica D., Ramies, David A., Li, Joanne, Spezia, Riccardo, Mappa, Silvia, Keng, Michael Kenneth
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Antitumor activity of cabozantinib (XL184) in a cohort of patients (pts) with differentiated thyroid cancer (DTC)
Cabanillas, Maria E., Brose, Marcia S., Ramies, David A., Lee, Yihua, Miles, Dale, Sherman, Steven I.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Efficacy of cabozantinib (XL184) in patients (pts) with metastatic, refractory renal cell carcinoma (RCC)
Choueiri, Toni K., Pal, Sumanta Kumar, McDermott, David F., Ramies, David A., Morrissey, Stephanie, Lee, Yihua, Miles, Dale, Holland, Jaymes, Dutcher, Janice P.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Activity of cabozantinib (XL184) in metastatic NSCLC: Results from a phase II randomized discontinuation trial (RDT)
Hellerstedt, Beth A., Edelman, Gerald, Vogelzang, Nicholas J., Kluger, Harriet M., Yasenchak, Christopher A., Shen, Xiaodong, Ramies, David A., Gordon, Michael S., Lara, Primo
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Activity of cabozantinib (XL184) in patients (pts) with metastatic, refractory renal cell carcinoma (RCC)
Choueiri, Toni K., Pal, Sumanta Kumar, McDermott, David F., Ramies, David A., Morrissey, Stephanie, Lee, Yihua, Miles, Dale, Holland, Jaymes S., Dutcher, Janice P.
Published in Journal of clinical oncology (10.02.2012)
Published in Journal of clinical oncology (10.02.2012)
Get full text
Journal Article
Activity of cabozantinib (XL184) in metastatic melanoma: Results from a phase II randomized discontinuation trial (RDT)
Gordon, Michael S., Kluger, Harriet M., Shapiro, Geoffrey, Kurzrock, Razelle, Edelman, Gerald, Samuel, Thomas A., Moussa, Ali H., Ramies, David A., Laird, A. Douglas, Schimmoller, Frauke, Shen, Xiaodong, Daud, Adil
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Activity of cabozantinib (XL184) in metastatic breast cancer (MBC): Results from a phase II randomized discontinuation trial (RDT)
Winer, Eric P., Tolaney, Sara, Nechushtan, Hovav, Berger, Raanan, Kurzrock, Razelle, Ron, Ilan-Gil, Schoffski, Patrick, Awada, Ahmad, Yasenchak, Christopher A., Burris, Howard A., Ramies, David A., Rafferty, Teresa, Shen, Xiaodong
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Evaluation of the Pharmacokinetics, Immunogenicity, and Safety of XmAb®2513 in the Ongoing Study XmAb2513-01: A Phase 1 Study of Every Other Week XmAb2513 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Patients with Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma
Younes, Anas, Zalevsky, Jonathan, Blum, Kristie A., Smith, Mitchell R, Fung, Henry C., Ramies, David A, Lawrence, Chris E, Combs, Daniel, Bloss, Jeffrey
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Pathogen Inactivation of Plasma Using S-59 and UVA Light Is Efficacious and Well Tolerated in Liver Transplant Surgery - The STEP AC Trial: 2002[A-453
Steadman, Randolph, Blackall, Douglas P., Petz, Lawrence D., Mintz, Paul D., Ramies, David A.
Published in Anesthesiology (Philadelphia) (01.09.2002)
Published in Anesthesiology (Philadelphia) (01.09.2002)
Get full text
Journal Article